The induction rate among single cephalic nulliparous women at term (≥ 37 weeks of gestation) increased from 17.5 % in 1994 to 39.4 % in 2016 and caesarean section rate increased from 21.5% (97/451) to 32.6% (437/1339) respectively. The induction rate among term multiparous women without previous caesarean section (group 4A) increased from 17% in 1994 (626/3677) to 28.8% (1005/3494) in 2016 and the respective caesarean section rates were 5.1% (32/626) in 1994 and 4.4% in 2016 (44/1005).
There were 8851 women delivered in 2016 of whom 3397 were in Robson group 1 and 2. Among these 56.7% (1925/3397) went into spontaneous labour, 39.4% (1339/3397) were induced and 3.9% (133/3397) had pre labour caesarean section. The corresponding number for multiparous women in Robson group 3 and 4 were 68.4% (2389/3494), 28.8% (1005/3494) and 2.9% (100/3494). Excluded from analysis from multiparous women group were 1069 women with at least 1 previous caesarean section and a single cephalic pregnancy (Robson group 5).
Patient demographics, method of induction, obstetric and neonatal outcome are shown in table 2. Of note, group 4A were significantly older and had significantly larger babies. However, the percentage of obese women (BMI => 30) was similar. More nulliparous women required prostaglandins combined with oxytocin infusion for induction. (Table 2).
Table 2: Patient demographics, method of induction, maternal and fetal outcome (NMH 2016)
|
Group 2A
|
Group 4A
|
95% CI
|
p-value
|
Age>=35 years
|
439/1339(32.8%)
|
531/1005(52.8%)
|
15.9859 to 23.9354
|
P < 0.0001
|
BMI=>30
|
166/1339(12.4%)
|
145/1005(14.4%)
|
-0.7663 to 4.8407
|
P = 0.1577
|
Prostaglandin gel/Propess
|
666/1339(49.7%)
|
348/1005(34.6%)
|
11.0857 to 19.0287
|
P < 0.0001
|
Oxytocin
|
961/1339(71.8%)
|
323/1005(32.1%)
|
35.8527 to 43.3627
|
P < 0.0001
|
Artificial rupture of membranes
|
882/1339(65.9%)
|
851/1005(84.7%)
|
15.3708 to 22.1234
|
P < 0.0001
|
Fetal blood sampling
|
380/1339(28.4%)
|
68/1005(6.8%)
|
18.6832 to 24.4419
|
P < 0.0001
|
Vaginal operative delivery
|
392/1339(29.3%)
|
57/1005(5.7%)
|
20.7305 to 26.3998
|
P < 0.0001
|
Full dilatation caesarean section
|
34/1339(2.5%)
|
2/1005(0.2%)
|
1.4173 to 3.2926
|
P < 0.0001
|
PPH=>1000ml
|
63/1339(4.7%)
|
27/1005(2.7%)
|
0.4345 to 3.5197
|
P = 0.0127
|
HIE
|
5/1339(0.4%)
|
0/1005(0%)
|
-0.0419 to 0.9081
|
P= 0.0448
|
Blood transfusion
|
45/1339(3.4%)
|
9/1005(0.9%)
|
1.3370 to 3.6902
|
P = 0.0001
|
OASIS
|
29/1339(2.2%)
|
12/1005(1.2%)
|
-0.1021 to 2.0640
|
P = 0.0694
|
Apgar<7 at 5 min.
|
20/1339(1.5%)
|
8/1005(0.8%)
|
-0.2310 to 1.5947
|
P = 0.1235
|
Cord pH<7.0
|
5/1339(0.4%)
|
2/1005(0.2%)
|
-0.3702 to 0.7284
|
P = 0.3920
|
Admission to Neonatal unit
|
405/1339(30.2%)
|
145/1005(14.4%)
|
12.4717 to 19.0337
|
P < 0.0001
|
Babies>=4 kg
|
242/1339(18.1%)
|
264/1005(26.3%)
|
4.8030 to 11.6306
|
P < 0.0001
|
Episiotomy
|
570/1339(42.6%)
|
85/1005(8.5%)
|
30.8686 to 37.1941
|
P < 0.0001
|
Epidural
|
1023/1339(76.4%)
|
517/1005(51.4%)
|
21.1281 to 28.7909
|
P < 0.0001
|
Electronic monitoring
|
1238/1339(92.5%)
|
913/1005(90.8%)
|
-0.5430 to 4.0358
|
P = 0.1384
|
Length of labour >12h
|
103/1339(7.7%)
|
9/1005(0.9%)
|
5.2656 to 8.4092
|
P < 0.0001
|
The caesarean rates among nulliparous women in spontaneous and induced labour, groups 1 and 2A, were 7.8% (151/1925) and 32.6% (437/1339) and among multiparous, group 3 and 4A were 1% (24/2389) and 4.4% (44/1005), respectively. (Table 3)
Table 3: Caesarean section rates among nulliparous and multiparous women in spontaneous and induced labour (NMH 2016)
|
Spontaneous labor
|
Induced labour
|
|
Nulliparous women
|
7.8%(151/1925)
|
32.6%(437/1339)
|
|
Multiparous women
|
1%(24/2389)
|
4.4%(44/1005)
|
|
Overall, the caesarean section rate by indication was lowest in both groups when the indication for induction was for fetal reasons or maternal pains. Among nulliparous women, the highest caesarean section rate by indication were for postdates pregnancies (=> 42weeks) 44 % and 48% for nonmedical reasons and late pregnancies < 42 weeks. (Table 4)
Table 4: Indications for induction among group 2A and 4A and the associated caesarean section rates (NMH 2016)
|
Group 2A (n=1339)
|
CS rate for group 2A
|
Group 4A
(n=1005)
|
CS rate for group 4A
|
Fetal reasons
|
32.5%(435)
|
26.4%(115/435)
|
27.5%(277)
|
4.3%(12/277)
|
SROM
|
24.4%(327)
|
33%(108/327)
|
14.7%(148)
|
6%(9/148)
|
Postdates (>=42 weeks)
|
14.8%(199)
|
44.2%(99/199)
|
12.8%(129)
|
3.9%(5/129)
|
PET/hypertension
|
11.8%(159)
|
29.6%(47/159)
|
5.8%(59)
|
6.7%(4/59)
|
Maternal reasons ( including [BD1] pains)
|
9%(121)
|
26.4%(32/121)
|
19.2%(193)
|
3.1%(6/193)
|
Nonmedical reasons/dates (<42 weeks)
|
7.3%(98)
|
48%(47/121)
|
19.8%(199)
|
3.9%(8/199)
|
Total
|
39.4%(1339)
|
32.6%(437/1339)
|
28.8%(1005)
|
4.4%(44/1005)
|
The indications for caesarean sections are shown in table 5 and as expected, the main difference between group 2A and 4A was the number indicated for dystocia and suspected fetal distress. (Table 5).
Table 5: Indication for cesarean delivery among Robson group 2A and 4A
|
Group 2A (n=1339)
|
Group 4A (n=1005)
|
Fetal reasons
|
7.5%(100)
|
1.0%(10)
|
Dystocia/IUA/ITT/FI
|
9%(121)
|
0.8%(8)
|
Dystocia/IUA/ITT/OC
|
5%(68)
|
0.7%(7)
|
Dystocia/IUA/PR
|
8.1%(108)
|
1.4%(14)
|
Dystocia (no oxytocin)
|
1.1%(15)
|
0.1%(1)
|
Dystocia/EUA/CPD/POP
|
1.9%(25)
|
0.4%(4)
|
Total
|
32.6%(437)
|
4.4%(44)
|